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Abstract

Purpose: The purpose of this study was to develop prioritised indicators to measure cancer patient
experience and thus guide quality improvement in the delivery of patient care.
Methods: A Delphi study, consisting of two surveys and three workshops, was employed to gather expert
opinions on the most important indicators to measure. Survey participants were 149 health professionals,
academics/technical experts and consumers. The first survey was based on a literature review which identified
105 elements of care within 14 domains of patient experience. These were rated on a 7-point Likert scale, with
‘1’ representing high importance. Elements with mean ratings between 1.0 and 2.0 were retained for the
second survey. The 43 least-important elements were omitted, four elements were revised and nine new
elements added. Consensus was defined as at least 70% of participants rating an element ‘1’ or ‘2’. Multivariate
and cluster analyses were used to develop 20 draft indicators, which were presented to 51 experts to refine and
prioritise at the three workshops.
Results: All elements in the second survey were rated ‘1’ or ‘2’ by 81% of participants. Workshop participants
agreed strongly on the four most important indicators: coordinated care, access to care, timeliness of the first
treatment, and communication. Other indicators considered highly important were follow-up care for
survivors; timeliness of diagnosis; information relating to side effects, pain and medication; comprehensibility
of information provided to patients; and needs assessment.
Conclusions: Experts identified priorities with a high level of consensus, providing a rigorous foundation for
developing prioritised indicators of quality in cancer patient experience.
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PATIENT EXPERIENCE INDICATORS
A DELPHI STUDY TO DEVELOP INDICATORS OF CANCER PATIENT EXPERIENCE
FOR QUALITY IMPROVEMENT

Abstract
Purpose: To develop prioritised indicators to measure cancer patient experience and thus
guide quality improvement in the delivery of patient care.

Methods: A Delphi study, consisting of two surveys and three workshops, was employed to
gather expert opinions on the most important indicators to measure. Survey participants were
149 health professionals, academics/technical experts and consumers. The first survey was
based on a literature review which identified 105 elements of care within 14 domains of
patient experience. These were rated on a 7-point Likert scale, with ‘1’ representing high
importance. Elements with mean ratings between 1.0 and 2.0 were retained for the second
survey. The 43 least-important elements were omitted, four elements were revised and nine
new elements added. Consensus was defined as at least 70% of participants rating an element
‘1’ or ‘2’. Multivariate and cluster analyses were used to develop 20 draft indicators, which
were presented to 51 experts to refine and prioritise at the three workshops.

Results: All elements in the second survey were rated ‘1’ or ‘2’ by 81% of participants.
Workshop participants agreed strongly on the four most important indicators: coordinated
care; access to care; timeliness of first treatment; and communication. Other indicators
considered highly important were: follow-up care for survivors; timeliness of diagnosis;
information relating to side effects, pain and medication; comprehensibility of information
provided to patients; and needs assessment.
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Conclusions: Experts identified priorities with a high level of consensus, providing a rigorous
foundation for developing prioritised indicators of quality in cancer patient experience.

Keywords
Patient experience; quality indicators; quality improvement; Delphi; cancer

3

PATIENT EXPERIENCE INDICATORS
A DELPHI STUDY TO DEVELOP INDICATORS OF CANCER PATIENT EXPERIENCE
FOR QUALITY IMPROVEMENT

Patient experience indicators in cancer care allow health practitioners to identify
opportunities for positive change in services and systems, leading to better cancer outcomes
[1]. They can be used to benchmark performance of cancer services at state, national and
international levels. The development of appropriate and acceptable cancer patient experience
indicators should be informed by what matters to patients and engage health care providers
and technical experts [1]. This article reports on the results of a structured consultation
process using the Delphi technique to develop prioritised indicators of cancer patient
experience. The study was commissioned by the Cancer Institute of New South Wales as an
important step in developing systems for monitoring and improving the delivery of health
services to cancer patients.
A literature review was conducted to identify domains (priority areas) in which cancer
patient experience indicators are relevant. This was an important first step because patient
experience is a broad concept that encompasses many aspects of the organisation and
delivery of health care [2]. Indicators may be generic and apply to patients’ experiences
irrespective of their reasons for requiring health care, as in the principles of the Picker
Institute [3], or specific to a condition and treatment setting, such as a cancer patient’s
experience of radiotherapy. In some clinical fields there are many well-defined indicators of
care quality [4, 5]; however, a recent review identified relatively few published indicators of
cancer care [6, 7].
A justification for the specific domains chosen for the Delphi study is provided by
current work in Scotland, England and Canada. For example, the National Health Service
(NHS), Scotland, aims to develop “cancer-specific … evidence-based indicators …
underpinned by patient experiences” in order to focus quality improvement activity on the
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areas that will have most impact on survival and effective care delivery [8, p.3]. In England,
the NHS National Cancer Patient Experience Survey (CPES) measures the experience of
cancer patients across nine domains, including access, care coordination, communication and
emotional support [9]. This tool has recently been adapted in Australia by the Victorian
Comprehensive Cancer Centre [10]. Performance of the Canadian cancer control system is
measured by indicators along the continuum of cancer control: prevention, screening,
diagnosis, treatment and person-centred perspective [11].
The Delphi technique has been employed to develop indicators for the quality of
cancer care in the Netherlands [12, 13], Taiwan [14], Japan [15] and Greece [16, 17]. These
studies used rating scales to develop a range of indicators within the following domains:


Communication [13, 16]



Physical support, symptom control [13, 15, 16]



Psychosocial support and care [13, 15, 16]



Patient-centred care, including multi-disciplinary teams [14]; shared decision making
[15]; and care coordination, timely diagnosis and treatment, and support for selfmanagement [13]



Equity of access for patients from regional areas [16];



Monitoring and surveillance during remission [13];



Care for families of cancer patients [15].
The aim of this study was to develop prioritised indicators of cancer patient

experience for use in guiding service improvement. Patient experience was envisaged as
covering most phases of the patient pathway (assessment, diagnosis and treatment), most care
settings (primary care, hospital inpatient and outpatient facilities, sub-acute facilities and
community services) and all tumour groups. In order to fulfil the aim of the study it was
5
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imperative to obtain a diverse range of expert views. While most commonly an expert will
have a relevant professional or academic qualification, consumers may be considered experts
because of their lived experience. The importance of involving consumers in the Delphi
process has been identified [18]. Compared with providers, consumers may have different
priorities [17]. The inclusion of patients and carers was therefore seen as appropriate and was
consistent with two previous Delphi studies that developed cancer care indicators [13, 16,
17].

METHODS

Design
The Delphi technique employs a series of surveys, interspersed with feedback to
participants, to obtain anonymous opinions from experts. There are no universally accepted
requirements or guidelines that specify, for example, the number of rounds or the definition
of consensus [4]. Nevertheless, the four commonly accepted characteristics of the Delphi
method have been incorporated into the current study: anonymity; iteration; controlled
feedback; and statistical analysis of the group response [19].

Participants
A purposive, criterion-based sampling approach was adopted. The participants’
primary criterion was their specialist knowledge, gained through experience or qualifications,
demonstrating interest in cancer patient experience and/or patient experience measurement.
Three categories of experts were sought: health care professionals, consumers and academics
or technical experts. Experts were identified through professional networks of team members,
examination of the authorship of key literature, and internet searching. Consumer

6

PATIENT EXPERIENCE INDICATORS
representation was obtained through participation of key consumer groups within New South
Wales and Australia.
At the end of the Round 2 survey, respondents were asked to indicate their interest in
participating in further consultation activities. Those who expressed interest were invited to a
consultation workshop.

Materials
The Round 1 questionnaire was based on a literature scan, which drew on previous
reviews [6, 7, 20], and patient experience measures and surveys used in Australia and
overseas. This identified 14 domains (Table 1) and 105 associated elements (specific aspects)
of cancer patient experience.
The questionnaire presented elements within each domain. Participants were asked
how important it was to measure each element or domain. This instruction was repeated at
the beginning of each section to remind participants that they should consider whether
measuring an aspect of care could be useful to inform quality improvement activities.
Each element within each domain was rated on a Likert-type scale from 1 High
importance to 7 Low importance. After rating all elements in a domain, participants were
asked to select the most important element. They were asked to comment and whether other
(new) elements should be included in that domain. After rating all 105 elements, they were
presented with the list of 14 domains and asked to rate them on the same seven-point scale
used for the elements. Finally, the list of 14 domains was presented again, and participants
were asked to select the seven most important domains and rank them in order of importance.
The procedure of rating and ranking the domains provided further insights into patterns
within the data set that revealed participants’ priorities, beyond those obtained by looking at
elements in isolation.
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The questionnaire was modified following analysis of the Round 1 data. Based on
mean ratings, 43 least important elements were eliminated. The aim of revising the
questionnaire was to reduce participant burden and encourage consensus. Elements that had a
mean rating of 2 or less in Round 1 were included in the Round 2 questionnaire. The cut
point for inclusion of elements for Round 2 was chosen because a mean score of 2 or less
indicated that most participants had rated the element as very important (lower scores =
greater importance). The percentage of participants who rated the elements as highly
important (i.e., a rating of ‘1’ or ‘2’) was also considered. The qualitative feedback from
Round 1 highlighted aspects of patient care that were not adequately covered, leading to the
revision of four elements and the creation of nine new elements. The Round 2 questionnaire
included 71 elements within the same 14 domains. The order in which domains were
presented was reversed to control for order effects and respondent fatigue. The questionnaires
were piloted to ensure the task was clear and participant burden was minimised.

Procedure
The Delphi questionnaires were developed and managed using REDCap (Research
Electronic Data Capture), a web-based application [21]. Robust security and access controls
were in place. The study was approved by the university’s human research ethics committee.
After approval, invitations were emailed to experts from the Deputy CEO of the
commissioning organisation; 183 invitations for Round 1 were delivered successfully.
In Round 2, respondents were given: (1) their own Round 1 rating for each element or
domain (inserted automatically via a computerised process to protect confidentiality); (2) the
percentage of respondents who gave the element or domain a rating of 1; and (3) the group
response in Round 1: mean and standard deviation.
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The draft indicators derived from these processes were then assessed and prioritised
by three expert groups in workshops (N=51). Participants were given 20 cards, each
representing an indicator. They were asked to select the 10 indicators that were most
important to measure and to sort them in order of priority, and this individual information
was then transferred onto forms for analysis. The group’s priorities were then discussed.

Data analysis
Questionnaire responses were exported from REDCap into an Excel spreadsheet and
SPSS for statistical analysis. Consensus (i.e., importance and agreement) was defined by
examining the data distribution, mean, median and percent of respondents rating an element
as highly important. To be considered important, a domain element had to obtain a mean
rating of between 1.0 and 2.0. The percentage of participants who nominated an element as
most important within a domain was also examined. For the domains, the ratings and the
rankings were considered when determining relative importance. The level of agreement was
defined as the percentage of participants who rated an element (or domain) as ‘1’ or ‘2’. At
least 70% agreement was required for consensus.
Hierarchical cluster analysis was used to investigate the structure of the ratings data as
a guide to reducing the large set of elements to a smaller set of indicators. Each round of the
Delphi survey was analysed separately. The data source for the cluster analysis was a
similarity matrix comprising the Pearson correlations among the element ratings. Correlation
coefficients are frequently used as similarity measures for cluster analysis in the social
sciences [22]. Hierarchical cluster analysis was chosen because it assumes that items are
nested within increasingly abstract categories. The technique does not generate fit statistics as
a range of solutions are possible. Principal components and scale analyses were also
conducted in developing measurement tools for summary indicators.
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RESULTS
Of the 183 invitations delivered for the Round 1 survey, 158 individuals responded
(86%) with 149 usable responses (81%). Only respondents who had been included in Round
1 analysis were invited to Round 2. A total of 112/149 surveys were returned (75%) and all
were included in the analysis. A description of the Delphi respondents is provided in Table 2.
Element ratings and ‘most important’ elements
Elements that received the highest mean ratings in Round 2 are presented in Table 3,
listed by domain. All Round 2 elements were rated as ‘1’ or ‘2’ by 81% of participants,
indicating both high importance and high agreement. Standard deviations of mean ratings
could be compared across the two Delphi rounds for 58 elements. For 52 elements, the
standard deviation decreased, providing another indication of movement towards consensus.

Domain ratings and rankings
Table 4 presents the ratings of the 14 domains of patient experience in both rounds of
the Delphi survey. Domains are listed in order of importance, with those receiving the lowest
mean ratings (highest importance) in Round 2 presented first. The percentage of participants
who gave a rating of either ‘1’ or ‘2’ (highly important) is shown for each domain. At least
90% of participants gave these ratings for the top six domains in Round 2, a marked change
from Round 1 when opinions were more varied. Table 4 also presents the percentage of
participants who ranked each domain in their ‘top 2’ (i.e., ranked either first or second). The
Round 2 domain rankings and ratings were highly consistent despite the constraints imposed
by the forced-choice format of the ranking task. In both tasks the participants identified the
same three domains – coordinated care, timeliness of care and communication by doctors – as
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the most important for measuring patient experience. Technical expertise of health
professionals and comprehensive information provided to patients were also considered
highly important in both ratings and rankings.

Structure of the data
In the cluster analysis, solutions offering around 20 clusters were selected as the
original project brief specified 20 prioritised indicators. All solutions included unattached
items that had not yet joined clusters. Solutions from the two surveys were consistent. For
domains in which multiple important elements were identified, a procedure for developing
summary indicators was adopted, based on previous work [8]. Other elements that remained
unattached to clusters across the two rounds were marked out as possible stand-alone
indicators. This resulted in a list of 20 draft indicators.

Final indicators
Four indicators were strongly endorsed by the workshop participants: coordinated
care; access to care; timeliness of first treatment; and communication (Table 5). These
indicators were considered the most important based on both the percentage of participants
including them in the top ten and the mean rank data. Figure 1 shows that these indicators
were most often ranked first, second or third by workshop participants.
There were another eight indicators with moderate to higher levels of endorsement
(45-63%): follow-up care/ survivorship, timeliness of diagnosis, aspects of information
provision, needs assessment, shared decision making, and psychosocial care. At least half the
participants included nearly all of these indicators in their top ten. The remaining 12
indicators had lower rates of endorsement (39% or less) by the workshop participants and
these may be considered of lesser importance.
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The workshop rankings established a priority order for the final suite of indicators
(Table 5). The wording of the indicators was refined during the workshops and through
subsequent discussions with the commissioning organisation.

DISCUSSION
This project identified cancer patient experience indicators that, if monitored
regularly, could guide service improvement and practice change. Expert participants in the
Delphi process were presented with elements and domains of cancer patient experience
derived from the literature. They were asked to judge which were the most important to
measure. Findings from the two rounds of Delphi surveys were used to gauge the experts’
priorities and to understand relationships in the data so that the large set of elements and
domains could be reduced to a list of 20 draft indicators as required in the project brief.
Participants in three workshops then ranked the draft indicators and their feedback was
incorporated into the final set of prioritised indicators of cancer patient experiences.
Cancer patient experiences were defined broadly. The resulting indicators are
therefore generic and have wide application across a range of cancer services. Although there
have been several published Delphi studies on cancer care quality indicators, one was specific
to breast cancer [14] and another focused on end-of-life care [15]. Delphi research on cancer
services in Greece focused on identifying areas in which improvement was most needed [16,
17] whereas in the Netherlands the focus was on patient-centred cancer care [12, 13].
Despite differences in emphasis and variations in the way the Delphi technique was
applied, there are similarities between the sets of indicators produced by those studies and the
current research. Most highlighted the importance of patient-centred care, including care
coordination, opportunities for the patient to participate in care planning and decision
making, and needs assessment to support multidisciplinary care and referral to specialist
services where required. Psychosocial support appeared consistently across the lists of
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indicators. Other important aspects of patient experience identified in the current research
were found in some of the previous Delphi studies. These included indicators relating to
communication, timeliness of diagnosis and treatment, access to care, and follow-up care for
cancer survivors. Some of these indicators, notably communication and information
provision, are supported by other recent work such as the development of generic cancer care
indicators for the NHS Scotland [8].
One sensitive methodological issue with the Delphi method is the definition of
consensus. The investigators must decide how agreement among participants will be
measured and, if the agreement rate is used, what cut-off will be used to define consensus.
The method used to define consensus varied across the previous Delphi studies reviewed for
this research. With each additional survey round, consensus is expected to increase; however,
the potential for bias increases with respondent fatigue and attrition. There is little scientific
evidence on which to base decisions about the optimal number of rounds [4]. Our decision to
conduct two Delphi rounds was therefore based on previous published studies. For consensus
to be reached, at least 70% of respondents in our study had to rate an element or domain as
highly important (either ‘1’ or ‘2’). This criterion was consistent with the 75% agreement
suggested by Keeney and colleagues in their review of the Delphi technique in nursing
research [24]. Determining consensus by level of agreement is meaningful when Likert-type
scales are used [19]. A response rate of at least 70% is recommended for Delphi studies to
reduce the possibility of bias [25]. This was achieved and exceeded in both survey rounds.
Use of the Delphi technique captured a wide range of views by protecting the
anonymity of respondents. However, the sample was biased towards females and respondents
based in New South Wales; priorities may differ in other populations. Another limitation was
the length of the questionnaire, which included many domain elements, raising the possibility
of order effects and respondent fatigue. The domains and elements of patient experience
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presented in the first Delphi survey were derived from a scan of the literature, which is a
recognised alternative approach to a qualitative initial round [4, 23]. To enhance consumer
participation, it may have been better to start with consumer focus groups to generate items;
this is the approach taken for the Dutch Consumer Quality Index [26]. Nevertheless, the
inclusion of a wide range of experts, including consumers, in the expert panel strengthens the
current study [18] and may promote acceptance of the final suite of indicators.
The commissioning organisation required a set of 20 prioritised indicators. Although
it is not feasible to implement so many indicators immediately, the list captures a broad range
of important aspects of patient experience, providing scope for a staged implementation
approach. The four most highly ranked indicators are most likely to be suitable for large-scale
implementation (for example at State level). The indicators with moderate levels of
endorsement may have potential for use by individual services seeking to improve specific
aspects of cancer care. Eight indicators were endorsed by 39% or less of the workshop
sample which suggests they may not be such a high priority for implementation.
A patient centred quality cancer system is responsive to the needs of patients, carers
clinicians and health systems [27]. Good outcomes are defined in terms of what is valuable to
the individual patient [27]. To serve this purpose, it is essential that patient experience
indicators for cancer care are meaningful, measurable and modifiable. Monitoring these
indicators must produce information to identify areas for service improvement and make a
difference to the way cancer services are delivered and, ultimately, to cancer patient
experiences. Consequently, as a second step in the development process, the 20 draft
indicators were presented to three workshops for further refinement and prioritisation. A
physical meeting following the last Delphi round is an acceptable strategy for exchanging
views and resolving uncertainties, as long as the meeting is well structured and moderated to
contain the influence of dominant personalities [4].
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The priorities in the final suite of indicators (Table 4) were highly consistent with
those established during the surveys. For example, coordinated care, the highest priority
indicator, was based on the “Coordinated and Integrated Care” domain which was most
highly rated of all domains in both surveys. This indicator focuses on care processes
including assistance with navigating the health system; it excludes two elements which, based
on the cluster analysis and workshop discussions, became separate indicators: needs
assessment and follow-up care/survivorship. The domain “Timeliness of care” rated second
in both surveys; at the workshops, this split into two indicators, both highly ranked:
timeliness of first treatment and timeliness of diagnosis. The cluster analysis suggested the
two domains of “Patient centred communication” could be combined, resulting in the highly
ranked indicator communication, which covers issues of respect, treating patients with dignity
and considering their needs and preferences. Another aspect of patient-centred care, focusing
on participation and empowerment, formed a separate indicator: shared decision making.
Two domains relating to information provision, each with many elements, were distilled
down to four indicators: information provision: side effects; care plan; information style
(comprehensibility) and information provision (tailored and accurate). Despite the changes
in wording and emphasis, the priority given to these issues in the workshop rankings largely
reflects their domain and element ratings in the surveys, providing further confirmation that
consensus has been achieved.
The Delphi data and multivariate analyses were used to suggest measurement tools for
some of the indicators, supported by an evidence-based rationale [28]. Further work is
necessary to support implementation, which may include a review of information systems
and patient experience measures to identify relevant data items and develop new data items
where required. There is a need for research to examine the extent to which measurement of
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an indicator may contribute to change in service provision and patient outcomes and to
identify mechanisms by which processes of service delivery affect patient outcomes.
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Table 1
1
2
3
4
5
6
7
8
9
10
11
12
13
14

List of domains
Domains of patient experience included in the Delphi survey
Comprehensiveness of information provided to patients
Style of information provision (e.g. whether written, understandable, consistent, etc.)
Patient centred communication by doctors
Patient centred communication by nurses and other health professionals
Technical expertise and knowledge of health professionals
Coordination and integration of care
Timeliness of care
Patient (or advocate) involvement in shared decision making
Provision of psychosocial guidance to patients
Comfort factors
Safety aspects
Sensitivity to special needs groups by services
Patient concerns about access to care
Assessment of patient experience and satisfaction by services
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Table 2

Delphi participants’ gender, state / territory and expert category

Demographics
Gender
Male
Female
State / territory
Australian Capital Territory
New South Wales
Northern Territory
Queensland
South Australia
Tasmania
Victoria
Western Australia
Other
Expert category
Healthcare professional
Consumer - patient
Consumer – carer
Academic/technical expert
TOTAL PARTICIPANTS

Round 1
N

%

Round 2
N

%

28
121

19
81

21
91

19
81

1
114
0
9
10
1
10
3
1

1
76
0
6
7
1
1
2
1

0
87
0
7
6
1
8
2
1

0
78
0
6
5
1
7
2
1

57
25
19
48
149

38
17
13
32
100

37
22
17
36
112

33
20
15
32
100
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Table 3

Ratings for most important elements in Round 2 survey, by domain

Element name

N
(R2)

Mean
(R2)

SD
(R2)

% rated
1 or 2

109

1.38

0.64

95

109

1.49

0.70

94

109

1.53

0.88

92

109

1.75

1.06

89

109

1.73

0.78

93

109

1.65

0.61

93

1.33

0.59

96

1.45

0.79

95

Coordination and integration of care
There is a well organised process of patient care through the care pathway
including all treatment modalities
There is a holistic assessment of the patient's physical, psychosocial,
supportive care and practical assistance needs
The patient is allocated a central point of contact to help coordinate their
care across their pathway of cancer treatment
The patient is assisted and guided in trying to navigate the health system as
it pertains to their care
The patient is referred to supportive services in a timely manner
The patient receives regular follow-up care (surveillance and monitoring)
after active treatment is completed*
Timeliness of care

The time between receiving confirmation of a cancer diagnosis and the
commencement of the first cancer treatment
110
The time to receive a confirmed diagnosis (e.g. from GP referral to
confirmation of diagnosis)
110
Patient centred communication by doctors
Effective communication by doctors

107

1.37

0.83

94

Doctors consider the patient's preferences and needs

107

1.49

0.83

92

Doctors' answers to patient questions can be easily understood

107

1.57

0.97

89

Doctors treat the patient with respect and dignity

107

1.48

0.93

90

The patient has confidence and trust in the doctor(s)

107

1.57

0.99

90

Doctors encourage the patient to ask questions

107

1.67

1.05

89

Comprehensiveness of information provided to patients
Information on treatment options including benefits and risks

107

1.21

0.58

96

Information on results of treatment and prognosis

107

1.39

0.72

93

Information on test results and diagnosis

107

1.45

0.90

90

Information on potential side effects, both short- and long-term

107

1.41

0.69

94

Information on pain management

107

1.48

0.78

91

107
1.59
Information on self-care and warning signs that may require the doctor's
attention
107
1.50
Patient centred communication by nurses and other health professionals

0.74

89

0.77

93

Effective communication by nurses

107

1.62

0.96

89

Nurses treat the patient with respect and dignity

107

1.48

0.93

91

Other health professional and hospital staff treat patients with respect and
dignity
Nurses consider patient's preferences and needs

107

1.57

0.88

92

107

Information on medication(s) use

1.75

0.87

89

The patient has confidence and trust in nurses

107
1.74
Technical expertise and knowledge of health professionals

1.02

89

Patients' confidence and trust in the doctors' knowledge and expertise

0.81

88

109
1.56
Patient (or advocate) involvement in shared decision making

The patient feels their own preferences are taken into account when
treatment decisions are made
The patient feels empowered by health professionals to take part in making

110

1.57

0.76

92

110

1.59

0.91

91
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Element name

N
(R2)

Mean
(R2)

SD
(R2)

% rated
1 or 2

Patients from regional, rural or remote areas do not report disruption to or
delays in their treatment plan due to their location
The patient has adequate access to chemotherapy services

110

1.41

0.55

97

110

1.36

0.66

96

The patient has adequate access to radiotherapy services

110

1.39

0.68

96

The patient has adequate access to specialist physicians

110

1.37

0.68

96

The patient has adequate access to hospital inpatient services

110

1.52

0.71

94

1.52

0.87

90

1.6

0.85

91

110
1.41
0.75
The patient is referred, when appropriate, to relevant psychosocial support
services
110
1.40
0.67
Style of information provision (e.g. whether written, understandable, consistent, etc.)

96

Patients receive accurate information about their cancer care

107

1.34

0.85

95

Information provided is easy to understand

107

1.36

0.57

95

107
1.79
A care plan for each treatment modality is recorded in the patient's medical
record
107
1.48
A copy of the care plan for each treatment modality (e.g. chemotherapy,
radiotherapy etc.) is shared with the patient
107
1.55
Assessment of patient experience and satisfaction by services

0.92

90

0.82

93

0.82

93

decisions about their care and treatment
Patient concerns about access to care

Safety aspects
It can be demonstrated that the patient is supported in managing their pain
safely (including medication and other therapies)
110
It can be demonstrated that the patient's medication is regularly reviewed
and monitored
110
Provision of psychosocial guidance to patients
The patient's psychosocial needs are addressed

Patients receive the amount of information they need

94

Information regarding patient experiences is collected by the service and
used to improve the organisation and delivery of care*
111
Sensitivity to special needs groups by services

1.54

0.74

91

Interpreters are available for patients when needed

110

1.43

0.94

93

110

1.7

0.91

88

110

1.82

0.87

88

110

1.52

0.74

92

110

1.65

0.80

88

Extra assistance is provided for people with other disabling or chronic
conditions
The health professionals are sensitive to differences in cultural perceptions
of cancer and its treatment*
The health professionals are sensitive to differences in the needs of other
special groups (e.g. elderly, people with disabilities, those with low health
literacy, those experiencing social disadvantage, etc.)*
Comfort factors
Where applicable, practical and logistical issues (e.g. travel, accommodation,
scheduling of appointments) are addressed so that patients can more easily
access the facilities where they are receiving care

Note. R2 = Round 2 (second survey). *These items were added or modified for Round 2 of the Delphi survey.
Low scores indicate high importance.
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Table 4

Domains in order of importance*

Domain
Coordination and integration of care
Timeliness of care
Patient centred communication by doctors
Comprehensiveness of information provided
to patients
Patient centred communication by nurses
and other health professionals
Technical expertise and knowledge of health
professionals
Patient (or advocate) involvement in shared
decision making
Patients’ concerns about access to care
Safety aspects of care
Provision of psychosocial guidance to
patients
Style of information provision (e.g. whether
written, understandable, consistent, etc.)
Assessment of patient experience and
satisfaction by services
Sensitivity to special needs groups by
services
Comfort factors associated with care

Round 1
SD
% rated 1 or 2
0.71
92
0.71
94
0.88
90

N**
138
138
138

Mean rating
1.39
1.43
1.54

138

1.55

0.81

138

1.78

138

Round 2
% rated 1 or 2
0.8
95
0.69
95
0.86
94

% ranked top 2
38
26
35

N**
112
112
111

Mean rating
1.38
1.43
1.49

SD

% ranked top 2
51
39
27

88

29

112

1.57

0.81

91

10

0.98

83

15

111

1.65

0.84

93

8

1.97

1.2

76

20

111

1.71

0.91

90

31

138

1.78

0.99

79

11

112

1.73

0.9

89

8

138
138

1.96
1.99

1.08
1.29

74
70

3
8

112
112

1.84
1.88

0.87
0.97

82
79

7
7

138

1.78

0.93

79

2

112

1.94

1.02

82

2

138

1.92

1.06

75

7

111

1.98

0.95

82

2

138

2.07

1.07

70

4

112

2.06

0.91

79

6

138

2.03

1.17

72

0

112

2.13

1.04

69

0

138

2.49

1.22

57

0

112

2.44

0.94

61

0

Note.* Order of domains is based on Round 2 mean ratings. Low scores indicate high importance. ** Round 1 rankings n=137, Round 2 rankings n=107.
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Table 5
Rank*
1

2

3

4

5

6

6

8

9

10

11

11

13

14

Final suite of prioritised cancer patient experience indicators

Indicators in rank order**
Coordinated Care:
Patients were provided with a coordinated process of care throughout their cancer
treatment pathways.
Access to Care:
Patients had appropriate access to all necessary modalities of cancer treatment for
their cancer (e.g. clinical, surgical, chemotherapy and radiotherapy services).
Timeliness of First Treatment:
The time between patients receiving confirmation of a cancer diagnosis and the
commencement of their first cancer treatment (i.e. the treatment interval) was
reported.
Communication:
Patients experienced excellent communication from health professionals during their
most recent cancer treatments.
Follow-up Care / Survivorship:
Patients were provided with a follow-up care plan (including self-management
strategies) that identified the health professionals responsible for their care
following completion of their major cancer treatments.
Timeliness of Diagnosis:
The time taken for patients to receive a confirmed cancer diagnosis (i.e. the
‘diagnostic interval’, from the first presentation to the GP or other medical
practitioner) was reported.
Information Provision (Side-effects):
Information was provided to patients (and/or their carers) so they knew how to
manage common side-effects from their most recent cancer treatments.
Information Style (Comprehensibility):
The service provided cancer patients with individually tailored information that they
were able to understand.
Needs Assessment:
Patients’ health care needs were assessed during their cancer treatment pathways
and responded to when needed.
Provision of Psychosocial Care (Patients):
Patients’ psychosocial needs were assessed and, when relevant, referrals to support
services occurred during their most recent cancer treatments.
Provision of Psychosocial Care (Carers):
Carers’ psychosocial needs were assessed and, when relevant, referrals to support
services occurred.
Shared Decision Making:
Patients felt as involved as they wished to be in sharing decisions about their most
recent care and treatments for cancer.
Information Provision (Tailored and Accurate):
Patients received individually tailored and accurate information from health care
professionals on diagnosis, cancer stage and type, treatment and prognosis for their
most recent cancer treatments.
Access (Location):
Patients did not experience unnecessary or inappropriate delays in access or
disruptions to their cancer treatment(s) due to their location.
Patient Experience:
Information on patients’ experiences of cancer treatment was collected at least
annually, including an analysis of service complaints and compliments, and this

% Ranking in
top 10
96

80

75

71

63

57

57

55

51

47

45

45

39

37
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Rank*

Indicators in rank order**

% Ranking in
top 10

information was used to improve service delivery.
15

16

17

17

19
20

Access (Logistics):
Logistical issues for patients (e.g. travel, accommodation) were addressed when
scheduling appointments, to facilitate patient access to cancer treatments.
Doctor’s Knowledge and Expertise:
Patients felt confidence and trust in the doctor’s knowledge and expertise for their
most recent cancer treatments.
Care Plan:
Patients were engaged in the development of their care plan for each cancer
treatment modality they experienced and the care plan was entered into their
medical record.
Safety (Pain):
Patients’ pain was assessed and patients felt supported in managing their pain safely
(including medication and other therapies) during their most recent cancer
treatments.
Safety (Medication):
Patients’ medications were monitored during their most recent cancer treatments.
Priority Population Groups:
Individually tailored support was provided as needed for cancer patients from
priority population groups (e.g. patients from CALD communities, patients with other
disabling conditions, patients experiencing social disadvantage).

37

33

29

29

27
25

Note. * Bold indicates that final ranking was within the top 10 indicators. **Ranking based on combined data
from all participants in the three consultation workshops, n=51. Where percent data is the same for two
indicators they are given the same priority ranking.
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Figure 1

Ranking of the 20 draft indicators by workshop participants (n=51)

Note. The proportion of participants who ranked a draft indicator in their top three (their three most important indicators) is represented by the black
areas. Dark grey and mid-grey have been used to indicate the proportion of participants ranking an indicator 4th to 7th and 8th to 10th respectively. The light
grey tails at the right of each bar represent the proportion of participants who did not assign a top ten ranking to that indicator.
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